The General Assembly of the Spanish Association of Biosimilars - Biosim has elected, today, its new representatives on the Board of Directors, corresponding to the statutorily planned renewal.
He has been re-elected as president of the Association Joaquín Rodrigo, on behalf of Sandoz, which had already carried out this responsibility since the creation of Biosim in 2015.
The Vice Presidency has fallen to jose edward gonzalez, from Rovi; the Secretariat in Javier Anitua, by Mylan; and the Treasury in Serrano Shell, from Pfizer.
The vowels have fallen to Ana Vieta (Amgen), Sergio Teixeira (Biogen), Pepa MarKnez (Kern), Teresa Millan (Lilly) and Naouel Zouaghi (mAbxience). In relation to the previous Board of Directors, Ana Vieta (Amgen), Sérgio Teixeira (Biogen) and Teresa Millán (Lilly) have joined it.
Composition of the New Board of Directors.
The new Board of Directors of Biosim has been constituted as follows:
Job | Laboratory | Rrepresentative |
President | Sandoz | Joaquín Rodrigo |
Vice President | R | jose edward gonzalez |
Secretary | Mylan | Javier Anitua |
Treasurer | pfizer | Serrano Shell |
Spokesperson | Amgen | Ana Vieta |
Spokesperson | Biogen | Sergio Teixeira |
Spokesperson | Kern | Pepa Mar[nez |
Spokesperson | Lilly | Teresa Millan |
Spokesperson | mAbxience | Naouel Zouaghi |